Results 101 to 110 of about 4,085 (262)

Ultrasound as a technology of reassurance? How pregnant women and health care professionals articulate ultrasound reassurance and its limitations [PDF]

, 2017
The premise that ultrasound technologies provide reassurance for pregnant women is well‐rehearsed. However, there has been little research about how this reassurance is articulated and understood by both expectant mothers and health care professionals ...
Griffiths, Frances, Roberts, Julie, Thomas, Gareth M.   +2 more
core   +6 more sources

Human chorionic gonadotropin (hCG) concentrations during the late first trimester are associated with fetal growth in a fetal sex-specific manner [PDF]

, 2017
Human chorionic gonadotropin (hCG) is a pregnancy-specific hormone that regulates placental development. hCG concentrations vary widely throughout gestation and differ based on fetal sex.
Barjaktarovic, M. (Mirjana), Jaddoe, V.W.V. (Vincent), Korevaar, T.I.M. (Tim), Peeters, R.P. (Robin), Rijke, Y.B. (Yolanda) de, Steegers, E.A.P. (Eric), Visser, T.J. (Theo)   +6 more
core   +1 more source

Evaluation of Array Comparative genomic Hybridisation in prenatal diagnosis of fetal anomalies: a multicentre cohort study with cost analysis and assessment of patient, health professional and commissioner preferences for array comparative genomic hybridisation

Efficacy and Mechanism Evaluation, 2017
Background: Current pathways for testing fetuses at increased risk of a chromosomal anomaly because of an ultrasound anomaly involve karyotyping after rapid aneuploidy exclusion.
Stephen C Robson, Lyn S Chitty, Stephen Morris, Talitha Verhoef, Gareth Ambler, Diana G Wellesley, Ruth Graham, Claire Leader, Jane Fisher, John A Crolla   +9 more
doaj   +1 more source

Risk assessment for fetal aneuploidy after nuchal translucency measurement [PDF]

, 2008
Neðst á síðunni er hægt að nálgast greinina í heild sinni með því að smella á hlekkinn View/OpenIn this article the focus is on the estimation of a likelihood ratio by using software which calculates the risk for trisomy 13, 18 and 21. It is based on the
Kristín Rut Haraldsdóttir
core  

Major Congenital Anomalies in Babies Born With Down Syndrome: A EUROCAT Population-Based Registry Study [PDF]

Previous studies have shown that over 40% of babies with Down syndrome have a major cardiac anomaly and are more likely to have other major congenital anomalies.
Addor, Marie-Claude, Arriola, Larraitz, Barisic, Ingeborg, Beres, Judit, Bianchi, Fabrizio, Budd, Judith, De Walle, Hermien, Dias, Carlos Matias, Dolk, Helen, Garne, Ester, Gatt, Miriam, Khoshnood, Babak, Klungsoyr, Kari, Latos-Bielenska, Anna, Loane, Maria, Morris, Joan K, Mullaney, Carmel, Nelen, Vera, Neville, Amanda J., O\u27Mahony, Mary, Queisser-Luft, Annette, Randrianaivo, Hanitra, Rankin, Judith, Rissmann, Anke, Rounding, Cath, Sipek, Antonin, Stoianova, Sylvia, Tucker, David, Wellesley, Diana, Yevtushok, Lyubov   +29 more
core   +1 more source

First- and Second-trimester Down Syndrome Screening: Current Strategies and Clinical Guidelines

Taiwanese Journal of Obstetrics & Gynecology, 2008
Down syndrome (DS) is the most common human disease caused by a structural chromosome defect. The original screening test for DS was maternal age or a history of a previously affected infant.
Sheng-Wen Shaw, Jenn-Jeih Hsu, Chien-Nan Lee, Ching-Hua Hsiao, Chih-Ping Chen, T'sang-T'ang Hsieh, Po-Jen Cheng   +6 more
doaj   +1 more source

Maternal Parvovirus B19 Infection Causing First-Trimester Increased Nuchal Translucency and Fetal Hydrops

Case Reports in Obstetrics and Gynecology, 2019
This is a case report of a 31-year-old primigravida who was diagnosed with an asymptomatic acute parvovirus B19 infection in the second trimester of pregnancy and its suspected association with an increased nuchal translucency (NT) measurement ...
Olivia Grubman, Farrah Naz Hussain, Zoe Nelson, Lois Brustman   +3 more
doaj   +1 more source

First‐trimester screening for Down syndrome in France combining fetal nuchal translucency measurement and biochemical markers [PDF]

, 2003
Françoise Müller, C Benattar, François Audibert, Nathalie Roussel, Sophie Dreux, Howard Cuckle   +5 more
openalex   +1 more source

Increased Nuchal Translucency and Pregnancy Outcomes: A Tertiary Center Data

Düzce Tıp Fakültesi Dergisi
Aim: This study aimed to evaluate the pregnancy outcomes of patients who applied to our clinic between the 11th and 14th weeks of pregnancy and whose nuchal translucency (NT) measurement was ≥1.5 multiples of the median (MoM).
Hanım Güler Şahin, Mustafa Bağcı, Erbil Karaman, Onur Karaaslan, Kazım Uçkan   +4 more
doaj   +1 more source

P10.21: Karyotype and outcome of 43 fetuses diagnosed in the first trimester with cystic hygroma in relation with nuchal translucency measurement [PDF]

, 2004
R. Kharrat, M. Yamamoto, Sophie Couderc, Y. Ville   +3 more
openalex   +1 more source